LDI (Low Dose Immunotherapy)
LDI (Low Dose Immunotherapy) is one of the many modalities being utilized by the doctors at Sophia Health Institute. In a nutshell, LDI calms an overactive immune response to a chosen antigen.
When a threat to the immune system is encountered, an inflammatory cascade is triggered. Inflammation is needed to kill and subdue the offending agent; however, it can have damaging effects and cause negative symptoms if it persists. In a healthy immune response, after the threat has been dealt with, the immune system returns to a resting state and inflammation ceases.
People with chronic illness
What we see in many people with chronic illness, is that the immune response fails to deactivate and excess inflammation remains. A hypersensitivity to the offender is developed. This is where LDI comes in. It can help to regulate and tone down the overactive response and desensitize the immune system to specific antigens.
LDI can be helpful in treating Lyme and other bacteria, chemicals, foods, inhalants, candida, viruses, and much more. Another alternative is to make an autologous remedy which is made from your own urine, saliva, or other body fluids. This ensures the specific antigens unique to you are used for the desensitization process.
The biggest and most exciting shift
LDI is a fairly new treatment modality, however similar predecessors have been in use for decades. In the 1960s, Dr. Leonard McEwen pioneered what we know to be the first type of immune desensitization called Enzyme Potentiated Desensitization (EPD). It is a form of immunotherapy that can treat different types of allergies. EPD evolved into Low Dose Allergen therapy (LDA) with the work of Dr. W.A Shrader Jr. Within the past few years, LDI has emerged as a further evolution to the earlier work of EPA/LDA. The biggest and most exciting shift from EPA/LDA to LDI is the ability to treat infectious agents. Dr Ty Vincent has been the leader in the LDI movement and a mentor to the doctors at Sophia.
Safely used on adults and kids
The beauty of LDI is that it can be safely used on adults and kids alike. The antigens used are dead and are highly diluted. To give you a sense of how dilute they are, a 6C dilution would be a 1,000,000,000,000 dilution of the antigen itself. Typical dilutions used in office are anywhere from 6C all the way up to 20C depending on the sensitivity of the person. Being dead antigens, they cannot transmit an infection to someone who is not infected with it already.
The LDI treatment is repeated at a minimum of every 7 weeks. If no response or positive results are obtained, they can be repeated every 7-10 days.
The newest updates from Dr. Ty Vincent, along with our own clinical experience have shown that we no longer need to inject the antigens. The treatment works just as effectively if the antigens are administered under the tongue and held there for a few minutes.
The big shift
The other big shift in LDI therapy is no longer needing the beta-glucuronidase enzyme to activate the antigen. Using the antigens alone in the correct dilution is sufficient for effectively calming an overactive immune response.
If you are interested in pursuing LDI therapy or have further questions, schedule a consult with one of the doctors at Sophia Health Institute.